Creative BioMart invited Dr. Michael R. Green to join us to provide an overview of scRNA-seq studies that have improved our understanding of CAR T-cell therapy and informed novel approaches to therapeutically target their mechanistic underpinnings. https://www.creativebiomart.net/single-cell-analysis-of-response-and-toxicity-following-cd19-car-t-cell-therapy-in-lymphoma.htm